Latest Breaking News On - மாற்றும் பொருளாதாரங்கள் - Page 1 : comparemela.com

UNCTAD s Richard Kozul-Wright on the Post-COVID World Economy: Out of the Frying Pan… Into the Fire?

Yves here. Lynn Fries and her guest Richard Kozul-Wright, chief economist at UNCTAD, look at the prospects for the global economy after Covid and aren’t keen about what they see. The off and on recovery has benefitted the rich and left the poor behind, for the same reasons that the aftermath of global financial increased inequality: policymakers don’t want to change a hyper-financialized system. Even though a growing number of economists and commentators share this high-level view, Konzul-Wright and Fries explore the various mechanisms that have produced this current system, the fragilities that result, and the prospects for meaningful reform.

United statesUnited kingdomEastern capeSouth africaSouth koreaCity ofRichard kozul wrightJimmy carterDevelopment strategiesInternational monetary fundEuropean unionDivision on globalizationWorld trade organizationLynn friesGlobal political economyUnited nations conference

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing News provided by Share this article Share this article Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) The proceeds will support the continued development and expansion of Clover s pipeline of protein-based vaccines and biologic cancer therapies CHENGDU, China, Feb. 22, 2021 /PRNewswire/ Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics as vaccines and therapeutics for the world s most debilitating diseases, today announced the completion of an oversubscribed $230 million Series C financing. This financing round brings Clover s total capital raised in the last 12 months to over $400 million (over RMB 2.5 billion). The Series C round was co-led by GL Ventures and Temasek, with participation from Oceanpine Capital, OrbiMed and existing investor Delos Capital.

Michael yiTemasek charterKatelyn caruso sharpeJoshua liangPublic affairsLifesci communicationsEuropean unionClover biopharmaceuticalsOceanpine capitalChief executive officerBoard directorHillhouse capitalQualified personTransforming economiesGrowing middle income populationsDeepening comparative advantages

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Michael yiTemasek charterKatelyn caruso sharpeJoshua liangPublic affairsLifesci communicationsEuropean unionChief executive officerBoard directorHillhouse capitalQualified personTransforming economiesGrowing middle income populationsDeepening comparative advantagesBiopharmaceuticals contactsமைக்கேல் இ

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Michael yiTemasek charterKatelyn caruso sharpeJoshua liangPublic affairsLifesci communicationsEuropean unionClover biopharmaceuticalsOceanpine capitalChief executive officerBoard directorHillhouse capitalQualified personTransforming economiesGrowing middle income populationsDeepening comparative advantages

Global energy majors lead pivot to Eavor s geothermal solution with USD$40 million investment

This investment will support Eavor’s aim to power the equivalent of 10 million homes by 2030 Investors in this round Include: bp Ventures, Chevron Technology Ventures, Temasek, BDC Capital, Eversource 1 and Vickers Venture Partners CALGARY, Alberta, Feb. 16, 2021 (GLOBE NEWSWIRE) Eavor Technologies Inc., the leader in scalable geothermal technology, has completed a USD$40 million (CAD$50.7 million) funding round. These investments, and the partnerships formed around them, are critical to the commercialization of the technology and to help Eavor scale its already extensive project pipeline. Eavor’s technology, known as Eavor-Loop™, uses the natural heat of the earth like a giant rechargeable battery. Fluids are heated by the earth and circulated in a closed network of underground wellbores, unlocking a reliable and consistent energy source. Eavor’s technology differs from other forms of geothermal in that it is a scalable “go anywhere” solution, harvesting ge

New yorkUnited statesNew hampshireHong kongSan diegoUnited kingdomCity ofKhalil binebineJohn redfernTemasek charterLinda liRaymond kongFelipe arbelaezJeffrey chiAmerica most responsible companiesKongzhong corp